Customization: | Available |
---|---|
Powder: | Yes |
Customized: | Customized |
Still deciding? Get samples of US$ 150/BAG
Request Sample
|
Suppliers with verified business licenses
Audited by an independent third-party inspection agency
Product Name | Mildronate | Assay: | 99% |
Standard | Enterprise standard | Appearance: | White Crystalline Powder |
CAS NO | 76144-81-5 | EINECS | 682-135-0 |
Minimum order quantity | 500g | Packing: | 1kg/aluminum foil bag; 25kg/drum |
ITEM
|
STANDARD
|
RESULTS
|
Appearance
|
White or almost white crystalline powder
|
White crystalline powder
|
Dissolution
|
Easily solubale in water, solubale in 95% alcohol
|
Complies
|
Indentification
|
(1) Should be positive respond (2) IR graphs should be conforms to the reference standard |
Complies
|
pH
|
7.0~9.0
|
7.94
|
Clarity
|
should be not more than 1# working standard solution
|
Complies
|
Color
|
Should be lighter than the standard solution
|
Complies
|
Optical transmission
|
Not less than 95%
|
99.2%
|
Water
|
19.0~21.0%
|
19.66%
|
Chlorides
|
Not more than 0.01%
|
Complies
|
Function:
1. Mildronate powder is a novel cardioprotective agent.
2.Mildronate acts on mitochondria at the cellular level to improve myocardial energy metabolism. In view of these drugs and other anti-myocardial ischemia significantly different, also known as cell anti-ischemic drugs.
3. Mildronate is a structural analog of carnitine that competes in the inhibition of butyrate betaine hydroxylase, thereby inhibiting the biosynthesis of carnitine, which directly inhibits the transport of carnitine-dependent fatty acids in mitochondria. Inhibition of carnitine biosynthesis can reduce the concentration of intracellular free carnitine and prevent isoproterenol-induced acyl carnitine accumulation.
Therefore, the drug has a significant protective effect on the myocardium, resulting in this protective effect at the same time on the hemodynamic parameters had no significant effect, cardiac blood supply and cardiac oxygen consumption was no significant change.Application:
1.Cardiovascular disease - stable angina, chronic heart failure, cardiomyopathy, functional cardiovascular system failure;
2.Acute and chronic ischemic attacks;
3.The ability to work under high physical and psychological load decreases;
4.Recovery from cerebrovascular disease, brain injury, and encephalitis.
5.Alcohol withdrawal symptoms.
As a professional health product supplier, we can customize Mildronate powder with different packing, Mildronate capusel with different bottles according to your formula and requests.
>Click here to get more information
Fladrafinil | ≥98.0% HPLC | 90212-80-9 |
Picamilon (Sodium) | ≥98%~101%Titration | 62936-56-5 |
Sunifiram | ≥99.5% HPLC | 314728-85-3 |
Unifiram | ≥99.0% HPLC | 272786-64-8 |
Tianeptine acid | ≥99.0% HPLC | 66981-73-5 |
Tianeptine sodium | ≥99.0% HPLC | 30123-17-2 |
Tianeptine Hemisukfate Monohydrate | ≥98.0%~102.0% HPLC | 66981-73-5 |
Galantamine Hydrobromide | ≥99.0% HPLC | 69353-21-5 |
Galanthamine | ≥99.0% HPLC | 357-70-0 |
Huperzine A | ≥1.0% and 99% HPLC | 102518-79-6 |
NSI-189 Freebase | ≥99.0% HPLC | 1270138-40-3 |
NSI-189 Phosphate | ≥99.0% HPLC | 1270138-41-4 |
PRL-8-53 | ≥99.0% HPLC | 51352-87-5 |
agomelatine | ≥99.0% HPLC | 138112-76-2 |
5a hydroxy laxogenin | ≥99.0% HPLC | 56786-63-1 |
Vincamine | ≥99.0% HPLC | 1617-90-9 |
Centrophenoxine | ≥99.0% HPLC | 3685-84-5 |
N-coumaroyldopamine | ≥99.0% HPLC | 103188-46-1 |
N-caffeoyldopamine | ≥99.0% HPLC | 103188-49-4 |
Goods weight |
Packing |
Shipping method |
Lead-time |
1-50kg |
Below 5kg Use Foil bag;5-25kg use two layer PP bag,then into master carton or cardboard drum |
International express |
1~3 days after your payment |
100-200kg |
25kg/drum,use two layer PP bag,then into cardboard drum |
Air shipping Sea Shipping |
3~5 days after your payment |
Over 500kg |
25kg/drum,use two layer PP bag,then into cardboard drum |
Sea shipping |
5~10 days after your payment |
Q1: Can I get some free sample?